获得性血友病A-话题@MedSci

#获得性血友病A#

2篇内容 | 748人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2178288, encodeId=7e5d21e8288e7, content=<a href='/topic/show?id=820e3228e1b' target=_blank style='color:#2F92EE;'>#利妥昔单抗#</a> <a href='/topic/show?id=73216852458' target=_blank style='color:#2F92EE;'>#环磷酰胺#</a> <a href='/topic/show?id=971388025d1' target=_blank style='color:#2F92EE;'>#获得性血友病A#</a>, objectTitle=AJH：单剂量利妥昔单抗联合糖皮质激素与环磷酰胺联合糖皮质激素治疗新诊断的获得性血友病A疗效比较, objectType=article, longId=807619, objectId=057b80e61966, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301015/1697393424174_4754896.jpeg, objectUrl=/article/show_article.do?id=057b80e61966, replyNumber=0, likeNumber=34, createdTime=2023-12-31, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=057b80e61966, moduleTitle=AJH：单剂量利妥昔单抗联合糖皮质激素与环磷酰胺联合糖皮质激素治疗新诊断的获得性血友病A疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=057b80e61966)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2177721, encodeId=494c21e772153, content=<a href='/topic/show?id=5a8be955621' target=_blank style='color:#2F92EE;'>#罕见病#</a> <a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a> <a href='/topic/show?id=959290e2483' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系障碍#</a> <a href='/topic/show?id=971388025d1' target=_blank style='color:#2F92EE;'>#获得性血友病A#</a>, objectTitle=2023年度巨献：中国罕见病领域十大医学研究出炉, objectType=article, longId=807173, objectId=2efc80e17361, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20231228/1703729896491_92910.png, objectUrl=/article/show_article.do?id=2efc80e17361, replyNumber=0, likeNumber=26, createdTime=2023-12-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2efc80e17361, moduleTitle=2023年度巨献：中国罕见病领域十大医学研究出炉, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2efc80e17361)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1573184, encodeId=123115e31844f, content=<a href='/topic/show?id=971388025d1' target=_blank style='color:#2F92EE;'>#获得性血友病A#</a>, objectTitle=Blood：Emicizumab治疗获得性血友病A, objectType=article, longId=199478, objectId=3c8b1994e856, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c8b1994e856, replyNumber=0, likeNumber=40, createdTime=2020-08-16, rootId=0, userName=hunizi010, userId=384f15824640, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c8b1994e856, moduleTitle=Blood：Emicizumab治疗获得性血友病A, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c8b1994e856)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573183, encodeId=314f15e318389, content=<a href='/topic/show?id=971388025d1' target=_blank style='color:#2F92EE;'>#获得性血友病A#</a>, objectTitle=Blood：获得性血友病A（AHA）的出血风险及对止血治疗的反应, objectType=article, longId=192495, objectId=d596192495c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d596192495c5, replyNumber=0, likeNumber=46, createdTime=2020-04-20, rootId=0, userName=hunizi010, userId=384f15824640, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d596192495c5, moduleTitle=Blood：获得性血友病A（AHA）的出血风险及对止血治疗的反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d596192495c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

获得性血友病A

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#利妥昔单抗# #环磷酰胺# #获得性血友病A#

AJH：单剂量利妥昔单抗联合糖皮质激素与环磷酰胺联合糖皮质激素治疗新诊断的获得性血友病A疗效比较

2023-12-31发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#罕见病# #Car-T细胞疗法# #视神经脊髓炎谱系障碍# #获得性血友病A#

2023年度巨献：中国罕见病领域十大医学研究出炉

2023-12-28发表于上海

hunizi010 (审核中...)

前往app查看评论内容

#获得性血友病A#

Blood：Emicizumab治疗获得性血友病A

2020-08-16

hunizi010 (审核中...)

前往app查看评论内容

#获得性血友病A#

Blood：获得性血友病A（AHA）的出血风险及对止血治疗的反应

2020-04-20

科室
- - 订阅+
  - 更多科室
工具
服务